Conmed (CNMD) Tops Q1 EPS by 8c; Hikes FY22 Revenue Guidance

Conmed (NYSE: CNMD) reported Q1 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $242.3 million versus the consensus estimate of $235.77 million.

GUIDANCE:

Conmed sees FY2022 revenue of $1.105-1.15 billion, versus the consensus of $1.09 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight